Purpose: This study is aimed at characterizing the type of retinal edema in the initial stages of retinopathy in type 2 diabetes. Methods: In this retrospective cross-sectional study, spectral domain optical coherence tomography (OCT) layer by layer analysis of the retina in association with OCT-Leakage, an algorithm to detect sites of low optical reflectivity, were used to examine eyes with minimal, mild, and moderate diabetic retinopathy (DR). Results: A total of 142 eyes from 142 patients (28% women) aged 52–88 years were imaged. Macular edema, either subclinical (SCME) or central-involved macular edema (CIME), was present in 43% of eyes in group 10–20, 41% of eyes in group 35, and 38% of eyes in group 43–47. The inner nuclear layer (INL) was the layer showing higher and most frequent increases in retinal thickness (79%). The edema was predominantly intracellular in group 10–20 (65%) and extracellular in groups 35 (77%) and 43–47 (69%). Conclusions: Eyes from diabetic patients in the initial stages of DR with different Early Treatment Diabetic Retinopathy Study gradings show similar prevalence of SCME and CIME, independent of the severity of the retinopathy. Retinal edema is located mainly in the INL and appears to be mostly extracellular except in the earliest stages of diabetic retinal disease where intracellular edema predominates.

1.
Klein
R
,
Klein
BE
,
Moss
SE
,
Davis
MD
,
DeMets
DL
. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (Chicago, Ill 1960).
1984
May;102(4):520–6.
2.
Krzystolik
MG
,
Strauber
SF
,
Aiello
LP
,
Beck
RW
,
Berger
BB
,
Bressler
NM
, et al.;
Diabetic Retinopathy Clinical Research Network
.
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema
.
Ophthalmology
.
2007
Aug
;
114
(
8
):
1520
5
.
[PubMed]
0161-6420
3.
Brown
JC
,
Solomon
SD
,
Bressler
SB
,
Schachat
AP
,
DiBernardo
C
,
Bressler
NM
.
Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography
.
Arch Ophthalmol
.
2004
Mar
;
122
(
3
):
330
5
.
[PubMed]
0003-9950
4.
Browning
DJ
,
Fraser
CM
.
The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema
.
Am J Ophthalmol
.
2008
Jan
;
145
(
1
):
149
54
.
[PubMed]
0002-9394
5.
Bressler
NM
,
Miller
KM
,
Beck
RW
,
Bressler
SB
,
Glassman
AR
,
Kitchens
JW
, et al.;
Diabetic Retinopathy Clinical Research Network
.
Observational study of subclinical diabetic macular edema
.
Eye (Lond)
.
2012
Jun
;
26
(
6
):
833
40
.
[PubMed]
0950-222X
6.
Bandello
F
,
Tejerina
AN
,
Vujosevic
S
,
Varano
M
,
Egan
C
,
Sivaprasad
S
, et al.;
EVICR.net
.
Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2
.
Ophthalmic Res
.
2015
;
54
(
3
):
112
7
.
[PubMed]
0030-3747
7.
Vujosevic
S
,
Midena
E
.
Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations
.
J Diabetes Res
.
2013
;
2013
:
905058
.
[PubMed]
2314-6745
8.
Farinha
C
,
Santos
T
,
Marques
IP
,
Marques
JP
,
Ribeiro
L
,
Figueira
J
, et al.
OCT-Leakage Mapping: A New Automated Method of OCT Data Analysis to Identify and Locate Abnormal Fluid in Retinal Edema
.
Ophthalmol Retina
.
2017
Nov
;
1
(
6
):
486
96
. 2468-7219
9.
Santos
AR
,
Alves
D
,
Santos
T
,
Figueira
J
,
Silva
R
,
Cunha-Vaz
JG
.
Measurements of Retinal Fluid by OCT Leakage in Diabetic Macular Edema: A Biomarker of Visual Acuity Response to Treatment
.
Retina
.
2019
Jan
;
39
(
1
):
52
60
.
[PubMed]
0275-004X
10.
Santos
T
,
Correia
A
,
Neves
CA
,
Schwartz
C
,
Miranda
T
,
Santos
AR
, et al.
Feasibility of automated interface segmentation of Cirrus HD-OCT data in normal and mild non proliferative diabetic retinopathy eyes
.
Invest Ophthalmol Vis Sci
.
2015
Jun
;
56
(
7
):
5953
5953
.0146-0404
11.
Santos
AR
,
Gomes
SC
,
Figueira
J
,
Nunes
S
,
Lobo
CL
,
Cunha-Vaz
JG
.
Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema
.
Ophthalmologica
.
2014
;
231
(
1
):
16
22
.
[PubMed]
0030-3755
12.
Kim
BY
,
Smith
SD
,
Kaiser
PK
.
Optical coherence tomographic patterns of diabetic macular edema
.
Am J Ophthalmol
.
2006
Sep
;
142
(
3
):
405
12
.
[PubMed]
0002-9394
13.
Santos
AR
,
Costa
,
Schwartz
C
,
Alves
D
,
Figueira
J
,
Silva
R
, et al.
OCT Baseline Predictors for Initial BCVA Response to Intravitreal anti-VEGF Treatment in Eyes with Diabetic Macular Edema. The CHARTRES study
.
Retina
.
2018
Jun
;
38
(
6
):
1110
9
.
[PubMed]
0275-004X
14.
Sun
JK
,
Lin
MM
,
Lammer
J
,
Prager
S
,
Sarangi
R
,
Silva
PS
, et al.
Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema
.
JAMA Ophthalmol
.
2014
Nov
;
132
(
11
):
1309
16
.;
Epub ahead of print
.
[PubMed]
2168-6165
15.
Friedman
SM
,
Almukhtar
TH
,
Baker
CW
,
Glassman
AR
,
Elman
MJ
,
Bressler
NM
, et al.;
Diabetic Retinopathy Clinical Research Network
.
Topical nepafenec in eyes with noncentral diabetic macular edema
.
Retina
.
2015
May
;
35
(
5
):
944
56
.
[PubMed]
0275-004X
16.
Cunha-Vaz
J
,
Santos
T
,
Ribeiro
L
,
Alves
D
,
Marques
I
,
Goldberg
M
.
OCT-leakage: A new method to identify and locate abnormal fluid accumulation in diabetic retinal edema
.
Invest Ophthalmol Vis Sci
.
2016
Dec
;
57
(
15
):
6776
83
.
[PubMed]
0146-0404
17.
Marques
IP
,
Alves
D
,
Santos
T
,
Mendes
L
,
Santos
AR
,
Lobo
C
, et al.
Multimodal Imaging of the Initial Stages of Diabetic Retinopathy. Different Disease Pathways in Different Patients
.
Diabetes
.
2018
;
•••
:
db181077
.
[PubMed]
0012-1797
18.
Henkind
P
,
Bellhorn
R
,
Schall
B
. Retinal Edema: Postulated Mechanism(s).
The Blood-Retinal Barriers Boston
.
MA
:
Springer US
;
1980
. pp.
251
68
.
19.
Klatzo
I
.
Presidental address. Neuropathological aspects of brain edema
.
J Neuropathol Exp Neurol
.
1967
Jan
;
26
(
1
):
1
14
.
[PubMed]
0022-3069
20.
Smelser
GK
,
Ishikawa
TP
. Electron microscopic studies of intra-retinal spaces: diffusion of particulate materials. In: (ed) RJ, editor. The Structure of the Eye Stuttgart, Schattauer-Verlag;
1965
. p. 109–20.
21.
Cheek
DB
,
Holt
AB
.
A review: extracellular volume in the brain—the relevance of the chloride space
.
Pediatr Res
.
1978
May
;
12
(
5
):
635
45
.
[PubMed]
0031-3998
22.
Iliff
JJ
,
Wang
M
,
Liao
Y
,
Plogg
BA
,
Peng
W
,
Gundersen
GA
, et al.
A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β
.
Sci Transl Med
.
2012
Aug
;
4
(
147
):
147ra111
.
[PubMed]
1946-6234
23.
Santos
AR
,
Ribeiro
L
,
Bandello
F
,
Lattanzio
R
,
Egan
C
,
Frydkjaer-Olsen
U
, et al.;
European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
.
Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project
.
Diabetes
.
2017
Sep
;
66
(
9
):
2503
10
.
[PubMed]
0012-1797
24.
Cunha-Vaz
J
,
Ribeiro
L
,
Lobo
C
.
Phenotypes and biomarkers of diabetic retinopathy
.
Prog Retin Eye Res
.
2014
Jul
;
41
:
90
111
.
[PubMed]
1350-9462
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.